Get started
Author

Laura Prieto‐Pinto

Observed names: L Prieto-Pinto, L. Prieto-Pinto, Laura Catalina Prieto-Pinto, Laura Prieto, Laura Prieto Pinto, Laura Prieto-Pinto, Prieto-Pinto, Laura
ORCID: 0000-0002-9489-2585
Observed ORCID: 0000-0002-9489-2585
OpenAlex ID: A5017430551
International experiences in multicriteria decision analysis (MCDA) for evaluating orphan drugs: a scoping review
2019 · P Lasalvia, L Prieto-Pinto, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 42
International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the Literature
2020 · Laura Prieto-Pinto, Nathaly Garzón-Orjuela, et al. · Value in Health Regional Issues · 29
Efficacy and safety of dabrafenib–trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF‐V600 mutation: A systematic review and network meta‐analysis
2019 · Nathaly Garzón‐Orjuela, Laura Prieto‐Pinto, et al. · Dermatologic Therapy · 22
PDF
Quality of life in refractory generalized myasthenia gravis: A rapid review of the literature
2019 · Nathaly Garzón-Orjuela, Laura van der Werf, et al. · Intractable & Rare Diseases Research · 18
PDF
Effectiveness assessment of maternal and neonatal health video clips in knowledge transfer using neuromarketing tools: A randomized crossover trial
2019 · Laura Prieto-Pinto, María Fernanda Lara-Díaz, et al. · PLoS ONE · 18
PDF
Efficacy and safety of faricimab for neovascular age-related macular degeneration: a systematic review and network meta-analysis
2024 · Daniel Samacá-Samacá, Claudia Hernández-Castillo, et al. · BMJ Open Ophthalmology · 17
PDF
Evaluation of the economic benefits, administration times, and patient preferences associated with the use of biotechnological drugs administered subcutaneously and intravenously in patients with cancer: a systematic review
2023 · Ana Parra, Claudia Hernández, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 16
PDF
Integrated Maternal Care Strategies in Low- and Middle-Income Countries: A Systematic Review
2022 · Laura Van der Werf, Silvia Evers, et al. · International Journal of Integrated Care · 13
Alectinib for treating patients with metastatic ALK -positive NSCLC: systematic review and network metanalysis
2023 · Daniel Samacá-Samacá, Laura Prieto-Pinto, et al. · Lung Cancer Management · 8
Cost-Effectiveness and Budget Impact Analysis of the Use of Faricimab in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Colombia
2025 · Daniel Samacá-Samacá, Antonio Robles, et al. · Journal of health economics and outcomes research · 6
Burden of disease of spinal muscular atrophy linked to chromosome 5q (5q-SMA) in Colombia
2023 · Yaneth Gil-Rojas, Fernando Suárez-Obando, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 4
Analysis of the experience of the geriatric fracture program in two institutions in Colombia: a reproducible model?
2021 · Carlos Mario Olarte, Mauricio Zuluaga, et al. · Colombia medica · 3
PDF
Efficacy and safety of dabrafenib‐trametinib in the treatment of unresectable or metastatic melanoma with BRAF V600 mutation: A systematic review and network meta‐analysis
2020 · Nathaly Garzón‐Orjuela, Laura Prieto‐Pinto, et al. · Dermatologic Therapy · 3
Óxido nítrico exhalado, asma y atopia: análisis en un panel de niños en Santiago, Chile
2013 · Daniella Vidal, Karla Yohannessen, et al. · Revista médica de Chile · 2
PDF
Factors contributing to the development of hemophilic arthropathy: A real-world study
2026 · Jesús Ardila, Melissa Diaz-Puentes, et al. · Annals of Hematology · 1
PDF
Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study
2025 · Andrés F. Cardona, Natalia Sánchez, et al. · The Lancet Regional Health - Americas · 1
Real-world outcomes and treatment patterns in Colombian patients with neovascular age-related macular degeneration and diabetic macular edema
2025 · Joshua Kock, José D. Miranda, et al. · The Pan-American Journal of Ophthalmology · 1
Disease burden of visual impairment in Colombia with emphasis in two retinal disorders
2024 · Yaneth Gil-Rojas, Carolina Sardi-Correa, et al. · Revista Sociedad Colombiana de Oftalmología · 1
PDF
Natalizumab in patients with multiple sclerosis in Colombia: a case series
2020 · Juan Raúl García Bonitto, Diana González-Bravo, et al. · Acta neurológica colombiana · 1
Pro10 Experiencia Internacional En El Uso De Análisis De Decisión Multicriterio (mcda) Para Evaluar Medicamentos Huérfanos: Scoping Review
2019 · P. Lasalvia, L. Prieto-Pinto, et al. · Value in Health Regional Issues · 1
El rol de los ensayos clínicos en la sostenibilidad financiera de los sistemas de salud: una revisión integrativa
2026 · Daniel Samaca, Sergio Cáceres Maldonado, et al. · Medicina
Economic benefit of expanding mammography screening for breast cancer in Colombia: A cost modelling analysis
2026 · Ana María Osorio, Daniel Samacá-Samacá, et al. · Public Health in Practice
Cost-Effectiveness Analysis of Trastuzumab-Emtansine as Adjuvant Therapy for HER2-Positive Early Breast Cancer with Residual Invasive Disease in Colombia
2026 · Daniel Samacá-Samacá, Diego Ballén, et al. · Journal of health economics and outcomes research
PDF
OP72 Clinical And Economic Impact Of The Availability Of Innovative Therapies For Advanced Lung Cancer In Latin America
2025 · Andrés F. Cardona, Natalia Sánchez, et al. · International Journal of Technology Assessment in Health Care
PDF
Corrigendum to “Clinical and economic impact of the availability of innovative therapies for advanced lung cancer in men in Latin America: a population-based secondary data study”- the Lancet Regional Health—Americas 2025; Volume 49: 101172; DOI: 10.1016/j.lana.2025.101172
2025 · Andrés F. Cardona, Natalia Sánchez, et al. · The Lancet Regional Health - Americas
Works count: 33
Citation count: 207
H-index: 8
I10-index: 8
Year
Topic
Type